KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Current Deferred Tax Assets: 2010-2014

Historic Current Deferred Tax Assets for Emergent BioSolutions (EBS) over the last 4 years, with Dec 2014 value amounting to $1.7 million.

  • Emergent BioSolutions' Current Deferred Tax Assets was N/A to $1.5 million in Q3 2015 from the same period last year, while for Sep 2015 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2014, which is N/A change from last year.
  • As of FY2014, Emergent BioSolutions' Current Deferred Tax Assets stood at $1.7 million, which was up 35.28% from $1.3 million recorded in FY2012.
  • In the past 5 years, Emergent BioSolutions' Current Deferred Tax Assets ranged from a high of $2.6 million in FY2010 and a low of $1.3 million during FY2012.
  • For the 2-year period, Emergent BioSolutions' Current Deferred Tax Assets averaged around $1.5 million, with its median value being $1.5 million (2012).
  • Data for Emergent BioSolutions' Current Deferred Tax Assets shows a maximum YoY crashed of 34.23% (in 2011) over the last 5 years.
  • Over the past 4 years, Emergent BioSolutions' Current Deferred Tax Assets (Yearly) stood at $2.6 million in 2010, then crashed by 34.23% to $1.7 million in 2011, then decreased by 27.15% to $1.3 million in 2012, then reached $1.7 million in 2014.